Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial

Geerts, 2008, Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition), Chest, 133, 381S, 10.1378/chest.08-0656

Caprini, 2006, Compliance with antithrombotic guidelines, Manag Care, 15, 49

Eriksson, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty, N Engl J Med, 358, 2765, 10.1056/NEJMoa0800374

Lassen, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty, N Engl J Med, 358, 2776, 10.1056/NEJMoa076016

Kakkar, 2008, Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial, Lancet, 372, 31, 10.1016/S0140-6736(08)60880-6

Rabinov, 1972, Roentgen diagnosis of venous thrombosis in the leg, Arch Surg, 104, 134, 10.1001/archsurg.1972.04180020014004

Colwell, 2003, Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement: a randomized, double-blind study, J Thromb Haemost, 1, 2119, 10.1046/j.1538-7836.2003.00368.x

Ginsberg, 2009, Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery, J Arthroplasty, 24, 1, 10.1016/j.arth.2008.01.132

Lassen, 2008, Randomized double-blind comparison of apixaban with enoxaparin for thromboprophylaxis after knee replacement: the ADVANCE-1 trial, Blood (ASH Annual Meeting Abstracts), 112, 31

Colwell, 2005, Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty, J Bone Joint Surg Am, 87, 2169, 10.2106/JBJS.D.02184

Bauer, 2001, Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery, N Engl J Med, 345, 1305, 10.1056/NEJMoa011099

Fuji, 2008, Randomized, double-blind, multi-dose efficacy, safety and biomarker study of the oral factor Xa inhibitor DU-176b compared with placebo for prevention of venous thromboembolism in patients after total knee arthroplasty, Blood (ASH Annual Meeting Abstracts), 112, 34

Strebel, 2002, Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?, Arch Intern Med, 162, 1451, 10.1001/archinte.162.13.1451

Raskob, 2003, Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery, Chest, 124, 379S, 10.1378/chest.124.6_suppl.379S

Cohen, 2005, Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery, Br J Surg, 92, 1335, 10.1002/bjs.5180